Women In Advanced Therapies: How Diverse Is The Sector Really?

Cell and gene therapy is a young biopharma sector approaching adolescence. As more companies transition from R&D to commercialization, has it got the balance right on diversity in senior leadership?

cell and gene therapy
• Source: Shutterstock

Following a recent Woman in Advanced Therapies event, part of Phacilitate’s 2023 Advanced Therapies Europe conference, In Vivo spoke with organizers, attendees and industry leaders about opportunities and challenges in the cell and gene therapy space.

Anecdotally, the advanced therapies sector was described as a place of greater equality at the top levels of leadership than...

More from Diversity & Inclusion

More from ESG